M&A Deal Summary |
|
|---|---|
| Date | 2020-05-11 |
| Target | Trukera Medical |
| Sector | Medical Products |
| Buyer(s) |
Accelmed
CRG |
| Deal Type | Going Private |
| Deal Value | 25M USD |
SEARCH BY
Try For Free 7-Day Free Trial
Accelmed is a global investment firm focused on providing investments in small and mid-cap private and public companies. The Firm looks to invest between $20 and $50 million in medical device companies and technologies with revenues greater than $30 million. Prospective transaction types include management buyouts and growth financings. Accelmed was formed in 2009 and is based in New York City.
| DEAL STATS | # |
|---|---|
| Overall | 10 of 18 |
| Sector (Medical Products) | 8 of 12 |
| Type (Going Private) | 1 of 1 |
| State (Texas) | 1 of 1 |
| Country (United States) | 7 of 14 |
| Year (2020) | 1 of 2 |
| Size (of disclosed) | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-06-27 |
TailorMed
New York, New York, United States TailorMed Medical provides technology to improve the financial performance of healthcare providers and reduce the financial hardship for patients. TailorMed was founded in 2016 and is based in New York, New York. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-08-31 |
NeuroPace
Mountain View, California, United States NeuroPace is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. Its novel and differentiated RNS System is the first and only commercially available, brain-responsive platform that delivers personalized, real-time treatment at the seizure source. This platform can drive a better standard of care for patients suffering from drug-resistant epilepsy and has the potential to offer a more personalized solution and improved outcomes to the large population of patients suffering from other brain disorders. NeuroPace was formed in 1997 and is based in Mountain View, California. |
Buy | - |
CRG is a healthcare focused investment firm focused on growth capital to commercial-stage public and private companies. CRG looks to commit $20 to $300 million that are developing next-generation healthcare products, technologies and services that address significant and substantial unmet medical needs. Specific areas of interest include biopharmaceuticals, specialty pharmaceuticals, medical devices, drug delivery, animal health, tools and diagnostics, and healthcare services. CRG was formed in 2003 and is headquartered in Houston, Texas.
| DEAL STATS | # |
|---|---|
| Overall | 12 of 13 |
| Sector (Medical Products) | 5 of 6 |
| Type (Going Private) | 1 of 1 |
| State (Texas) | 2 of 3 |
| Country (United States) | 11 of 12 |
| Year (2020) | 1 of 1 |
| Size (of disclosed) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-08-08 |
Cefaly
Seraing, Belgium Cefaly is a manufacturer and marketer of neuro-modulating medical devices for the prevention and treatment of migraines. The CEFALY device is externally applied by the patient to the forehead to deliver electrical impulses to the trigeminal nerve, a critical component of the nervous system involved in almost all migraines. Cefaly was founded in 2004 and is based in Seraing, Belgium. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-03-25 |
Alignment Healthcare
Orange, California, United States Alignment Healthcare provides healthcare management services to providers, health plans, and hospitals. The company offers an end-to-end continuous care program, including clinical care coordination, risk management capabilities, and IT enablement. Alignment Healthcare was incorporated in 2013 and is headquartered in Orange, California. |
Sell | - |
